Paul Saladino· MD
And a recent study from Stanford suggests 50-85x higher seroprevalence than previously estimated.
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
And a recent study from Stanford suggests 50-85x higher seroprevalence than previously estimated.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
there's a study that was done at Stanford for the Santa Clara County that showed 50 to 85 X